{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:44:28Z","timestamp":1786373068880,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1991,1,1]],"date-time":"1991-01-01T00:00:00Z","timestamp":662688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1991,1]]},"DOI":"10.1007\/bf01644730","type":"journal-article","created":{"date-parts":[[2005,5,7]],"date-time":"2005-05-07T04:37:49Z","timestamp":1115440669000},"page":"S19-S24","source":"Crossref","is-referenced-by-count":2,"title":["Vergleich der Nebenwirkungsprofile verschiedener Substanzen wie Penicilline, Tetrazykline, Sulfonamide und Chinolone","Adverse reactions to penicillins, tetracyclines, sulfonamides and quinolones"],"prefix":"10.1007","volume":"19","member":"297","reference":[{"key":"CR1","first-page":"501","volume-title":"Meyler's side effects of drugs","author":"R. Hoign\u00e9","year":"1988","unstructured":"Hoign\u00e9, R., Keller, H., Sonntag, R. Penicillins, cephalosporins and tetracyclines. In:M. N. G. Dukes. (ed.): Meyler's side effects of drugs, eleventh edition. Elsevier, Amsterdam - New York - Oxford 1988, pp. 501\u2013542.","edition":"eleventh editio"},{"key":"CR2","first-page":"603","volume-title":"Meyler's side effects of drugs","author":"R. Hoign\u00e9","year":"1988","unstructured":"Hoign\u00e9, R., Malinverni, R., Schaffer, K. Sulfonamides and miscellaneous antibacterial and antiviral drugs. In:M. N. G. Dukes (ed. Meyler's side effects of drugs, eleventh edition. Elsevier, Amsterdam - New York - Oxford 1988, pp. 603\u2013632.","edition":"eleventh editio"},{"key":"CR3","first-page":"581","volume-title":"Meyler's side effects of drugs","author":"C. B. M. Tester-Dalderup","year":"1988","unstructured":"Tester-Dalderup, C. B. M. Antiprotozoal drugs. In:M. N. G. Dukes (ed.): Meyler's side effects of drugs, eleventh edition. Elsevier Amsterdam - New York - Oxford 1988, pp. 581\u2013602.","edition":"eleventh editio"},{"key":"CR4","first-page":"28","volume":"12","author":"P. Ball","year":"1989","unstructured":"Ball, P. Adverse reactions and interactions of fluoroquinolones. Clin. Invest. Med. 12 (1989) 28\u201334.","journal-title":"Clin. Invest. Med."},{"key":"CR5","doi-asserted-by":"crossref","unstructured":"Davey, P. G.: Post-marketing surveillance of the quinolones: A view from Great Britain: Reviews of infectious diseases. Vol II, Suppl. 5, (1989).","DOI":"10.1093\/clinids\/11.Supplement_5.S1402"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/bmj.299.6694.303","volume":"299","author":"D. Huminer","year":"1989","unstructured":"Huminer, D., Cohen, J. D., Majadla, R., Dux, S. Hypersensitivity vasculitis due to ofloxacin. Br. Med. J. 299 (1989) 303.","journal-title":"Br. Med. J."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/bmj.299.6700.658","volume":"299","author":"J. L. Pace","year":"1989","unstructured":"Pace, J. L., Gatt, P. Fatal vasculitis associated with ofloxacin. Br. Med. J. 299 (1989) 658\u2013659.","journal-title":"Br. Med. J."},{"key":"CR8","doi-asserted-by":"crossref","unstructured":"Stahlmann, R., Lode, H.: Safety overview: Toxicity, adverse effects and drug interactions. In:V. T. Andriole (ed.): The Quinolones; Academic Press limited, 1988.","DOI":"10.1016\/B978-0-12-059515-0.50010-X"},{"issue":"Suppl. 6C","key":"CR9","first-page":"S78","volume":"87","author":"K. J. Tack","year":"1989","unstructured":"Tack, K. J., Smith, J. A. The safety profile of ofloxacin. Am. J. Med. 87 (Suppl. 6C) (1989) S78-S81.","journal-title":"Am. J. Med."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/AAC.34.1.173","volume":"34","author":"M. Watanabe","year":"1990","unstructured":"Watanabe, M., Kotera, Y., Yosue, K., Inoue, M., Mitsuhashi, S. In vitro emergence of quinolone-resistant mutants ofEscherichia coli, Enterobacter cloacae, andSerratia marcescens. Antimicrob. Agents Chemother. 34 (1990) 173\u2013175.","journal-title":"Antimicrob. Agents Chemother."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1007\/BF01975175","volume":"8","author":"J. S. Wolfson","year":"1989","unstructured":"Wolfson, J. S. Quinolone antimicrobial agents: Adverse effects and bacterial resistance. Eur. J. Clin. Microbiol. Infect. Dis. 8 (1989) 1080\u20131092.","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"CR12","first-page":"748","volume":"40","author":"K. A. Brensing","year":"1989","unstructured":"Brensing, K. A., Rueddel, H., Schmieder, R. E., Schulte, W. Visusund H\u00f6rverlust als Komplikation der Therapie mit Ofloxacin. Med. Welt. 40 (1989) 748\u2013751.","journal-title":"Med. Welt."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0029-1235573","volume":"115","author":"S. Harder","year":"1990","unstructured":"Harder, S., Shah, P. M., Staib, A. H. Zentralnerv\u00f6se Nebenwirkungen und Hemmung der Methylxanthinelimination. Dtsch. med. Wschr. 115 (1990) 270\u2013273.","journal-title":"Dtsch. med. Wschr."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2007-1014570","volume":"22","author":"M. Zaudi","year":"1989","unstructured":"Zaudi, M., von Bose, M., Weber, M., Bremer, D., Zieglg\u00e4nsberger, W. Psychotoxic effects of ofloxacin. Pharmacopsychiat. 22 (1989) 11\u201315.","journal-title":"Pharmacopsychiat."},{"key":"CR15","first-page":"735","volume":"56","author":"E. Pertuiset","year":"1989","unstructured":"Pertuiset, E., Lenior, G., Jehanne, M., Douchain, F., Guillot, M., Menkes, C. J. Tol\u00e9rance articulaire de la p\u00e9floxacine et de l'ofloxacine chez les enfants et adolescents atteints de mucoviscidose. R\u00e9vue du Rhumatisme 56 (1989) 735\u2013740.","journal-title":"R\u00e9vue du Rhumatisme"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000238444","volume":"32","author":"S. B. Thornsteinsson","year":"1986","unstructured":"Thornsteinsson S. B., Bergan, T., Oddsdottir, S., Rohwedder, R., Holm, R. Crystalluria and ciprofloxacin, influence of urinary pH and hydration. Chemotherapie 32 (1986) 408\u2013417.","journal-title":"Chemotherapie"},{"issue":"Suppl. 5A","key":"CR17","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/0002-9343(89)90028-4","volume":"87","author":"R. K. Polk","year":"1989","unstructured":"Polk, R. K. Drug-drug interactions with ciprofloxacin and other fluoroquinolones. Am. J. Med. 87 (Suppl. 5A) (1989) S76-S81.","journal-title":"Am. J. Med."}],"container-title":["Infection"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01644730.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01644730\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01644730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T08:32:45Z","timestamp":1557217965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01644730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,1]]},"references-count":17,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1991,1]]}},"alternative-id":["BF01644730"],"URL":"https:\/\/doi.org\/10.1007\/bf01644730","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,1]]}}}